Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailNuclear Medicine/ Radiopharmaceuticals Market

Nuclear Medicine/ Radiopharmaceuticals Market Soars to USD billion , witnessing a CAGR of 19.5 during the forecast period 2024-2032

Nuclear Medicine/ Radiopharmaceuticals Market by Type (Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, Others], SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, Others]}, Therapeutics {Ra-223, Sm-153, Lu-177, I-131, Y-90, Others}), by Application (Neurology, Cardiology, Oncology, Others), by End User (Hospitals & Clinics, Diagnostic Centers, Others), by North America (U.S., Canada) Forecast 2024-2032

Jun 25 2024
Base Year: 2023
150 Pages
Market Research Future Logo

Nuclear Medicine/ Radiopharmaceuticals Market Soars to USD billion , witnessing a CAGR of 19.5 during the forecast period 2024-2032

Key Insights

The Nuclear Medicine/ Radiopharmaceuticals Marketsize was valued at USD 7.53 USD billion in 2023 and is projected to reach USD 26.20 USD billion by 2032, exhibiting a CAGR of 19.5 % during the forecast period.Nuclear medicine means using radioactive inside of human body. It shows how tissues or organs are functioning or it can kill damaged and diseased tissues directly. Nuclear medicine is used to see how tissues or organs are functioning. Usually, the tracer, which however consists, of the radioactive materials, is ingested, breathed, or taken in. After the tracer has been injected, a radiation detector is used and is set to either measure how much of it is absorbed in the organ or how it reacts in the organ or tissue that are being examined. The principle of nuclear medicine such as diagnosis is the scans of heart, lung, kidneys, gallbladder, and thyroid. Gives overview of how organs, tissues and cells are engineered. Different modalities based on imaging show anatomical structure. It can also be used in strikingly accurate targeted treatment to destroy or damage harmful or cancer cells, decrease the tumor’s size, and reduce pain.

Nuclear Medicine/ Radiopharmaceuticals Market Research Report - Market Size, Growth & Forecast

Nuclear Medicine/ Radiopharmaceuticals Trends

  • Growing prevalence of chronic diseases such as cancer and cardiovascular diseases.
  • Technological advancements in radiopharmaceutical production and imaging techniques.
  • Increased adoption of personalized medicine and targeted therapies.
  • Government initiatives to promote nuclear medicine and research.

Driving Forces: What's Propelling the Nuclear Medicine/ Radiopharmaceuticals Market

  • Rising demand for early disease diagnosis and monitoring.
  • Advancements in radioisotope production and labeling techniques.
  • Expanding applications of radiopharmaceuticals in targeted drug delivery and therapy.
  • Favorable reimbursement policies for nuclear medicine procedures.

Challenges and Restraints in Nuclear Medicine/ Radiopharmaceuticals Market

  • Limited reimbursement for certain nuclear medicine procedures.
  • Concerns over radiation exposure and radioisotope availability.
  • Stringent regulatory requirements for nuclear medicine products.
  • Lack of skilled professionals in nuclear medicine departments.

Emerging Trends in Nuclear Medicine/ Radiopharmaceuticals

  • Development of theranostic radiopharmaceuticals for simultaneous diagnosis and therapy.
  • Advancements in artificial intelligence (AI) and machine learning for image interpretation and analysis.
  • Growing focus on personalized medicine and patient-specific treatment plans.
  • Integration of nuclear medicine with other imaging modalities such as PET-MRI and SPECT-CT.

Growth Catalysts in Nuclear Medicine/ Radiopharmaceuticals Industry

Nuclear Medicine/ Radiopharmaceuticals Market Growth

  • Government funding for nuclear medicine research and infrastructure.
  • Collaboration between academia, industry, and healthcare providers.
  • Development of new radiopharmaceuticals and innovative imaging techniques.
  • Increasing awareness about the benefits of nuclear medicine in early disease detection and treatment.

Market Segmentation: Nuclear Medicine/ Radiopharmaceuticals Analysis

Type:

  • Diagnostic
  • Therapeutic

Application:

  • Neurology
  • Cardiology
  • Oncology
  • Others

End-user:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Leading Players in the Nuclear Medicine/ Radiopharmaceuticals Market

  • Lantheus Medical Imaging, Inc. (U.S.)
  • Cardinal Health (U.S.) 
  • Norgine B.V. (Netherlands)
  • Nordion (Canada) Inc. (Canada) 
  • Bayer AG (Germany)
  • Curium (France)
  • Advanced Accelerator Applications (Novartis AG) (France) 
  • Bracco Diagnostic Inc. (U.S.)
  • Jubilant Pharmova Limited (India)
  • GE Healthcare (General Electric Company) (U.S.) 

Significant developments in Nuclear Medicine/ Radiopharmaceuticals Sector

  • In 2021, Lantheus Medical Imaging acquired Progenics Pharmaceuticals for USD 2.1 billion, expanding its portfolio of nuclear medicine products.
  • In 2022, Cardinal Health partnered with Curium to distribute its radiopharmaceuticals in the United States.

Comprehensive Coverage Nuclear Medicine/ Radiopharmaceuticals Market Report

  • Market Overview
  • Market Dynamics
  • Market Segmentation
  • Competitive Landscape
  • Regional Analysis
  • Growth Catalysts
  • Challenges and Restraints
  • Key Insights

Regional Insight

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

DROCT

  • Drivers
  • Restraints
  • Opportunities
  • Challenges
  • Threats

Pricing Analysis

  • Historical Pricing Analysis
  • Current Pricing Analysis
  • Future Pricing Scenario Analysis

Import And Export Analysis

  • Import Analysis
  • Export Analysis

Segmentation

  • Type Segmentation
  • Application Segmentation
  • End-user Segmentation

Patent/Trademark Analysis

  • Patent Analysis
  • Trademark Analysis

Nuclear Medicine/ Radiopharmaceuticals Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 19.5% from 2018-2032
Segmentation
    • By Type
      • Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F
      • 68Ga
      • 68Cu
      • 11C
      • Others]
      • SPECT Radiopharmaceuticals [Technetium-99m
      • Iodine-123
      • Xenon-133
      • Thallium-201
      • Others]}
      • Therapeutics {Ra-223
      • Sm-153
      • Lu-177
      • I-131
      • Y-90
      • Others}
    • By Application
      • Neurology
      • Cardiology
      • Oncology
      • Others
    • By End User
      • Hospitals & Clinics
      • Diagnostic Centers
      • Others
  • By Geography
    • North America
      • U.S.
      • Canada

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. How has Increasing Prevalence of Obesity Propelled the Market Growth?
      • 3.3. Market Restrains
        • 3.3.1. Alternatives Used for Diagnosis of CT and MRI to Limit Market Growth
      • 3.4. Market Trends
        • 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Type
      • 5.1.1. Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F
      • 5.1.2. 68Ga
      • 5.1.3. 68Cu
      • 5.1.4. 11C
      • 5.1.5. Others]
      • 5.1.6. SPECT Radiopharmaceuticals [Technetium-99m
      • 5.1.7. Iodine-123
      • 5.1.8. Xenon-133
      • 5.1.9. Thallium-201
      • 5.1.10. Others]}
      • 5.1.11. Therapeutics {Ra-223
      • 5.1.12. Sm-153
      • 5.1.13. Lu-177
      • 5.1.14. I-131
      • 5.1.15. Y-90
      • 5.1.16. Others}
    • 5.2. Market Analysis, Insights and Forecast - by Application
      • 5.2.1. Neurology
      • 5.2.2. Cardiology
      • 5.2.3. Oncology
      • 5.2.4. Others
    • 5.3. Market Analysis, Insights and Forecast - by End User
      • 5.3.1. Hospitals & Clinics
      • 5.3.2. Diagnostic Centers
      • 5.3.3. Others
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
  6. 6. North America Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
      • 6.1. Market Analysis, Insights and Forecast - By Type
        • 6.1.1. Diagnostic and Therapeutic
      • 6.2. Market Analysis, Insights and Forecast - By Application
        • 6.2.1 Neurology
        • 6.2.2 Cardiology
        • 6.2.3 Oncology
        • 6.2.4 and Others
      • 6.3. Market Analysis, Insights and Forecast - By End-user
        • 6.3.1 Hospitals & Clinics
        • 6.3.2 Diagnostic Centers
        • 6.3.3 and Others
      • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 6.4.1 United States
        • 6.4.2 Canada
        • 6.4.3 Mexico
  7. 7. South America Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
      • 7.1. Market Analysis, Insights and Forecast - By Type
        • 7.1.1. Diagnostic and Therapeutic
      • 7.2. Market Analysis, Insights and Forecast - By Application
        • 7.2.1 Neurology
        • 7.2.2 Cardiology
        • 7.2.3 Oncology
        • 7.2.4 and Others
      • 7.3. Market Analysis, Insights and Forecast - By End-user
        • 7.3.1 Hospitals & Clinics
        • 7.3.2 Diagnostic Centers
        • 7.3.3 and Others
      • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 7.4.1 Brazil
        • 7.4.2 Argentina
        • 7.4.3 Rest of South America
  8. 8. Europe Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
      • 8.1. Market Analysis, Insights and Forecast - By Type
        • 8.1.1. Diagnostic and Therapeutic
      • 8.2. Market Analysis, Insights and Forecast - By Application
        • 8.2.1 Neurology
        • 8.2.2 Cardiology
        • 8.2.3 Oncology
        • 8.2.4 and Others
      • 8.3. Market Analysis, Insights and Forecast - By End-user
        • 8.3.1 Hospitals & Clinics
        • 8.3.2 Diagnostic Centers
        • 8.3.3 and Others
      • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 8.4.1 Germany
        • 8.4.2 France
        • 8.4.3 Italy
        • 8.4.4 United Kingdom
        • 8.4.5 Netherlands
        • 8.4.6 Rest of Europe
  9. 9. Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
      • 9.1. Market Analysis, Insights and Forecast - By Type
        • 9.1.1. Diagnostic and Therapeutic
      • 9.2. Market Analysis, Insights and Forecast - By Application
        • 9.2.1 Neurology
        • 9.2.2 Cardiology
        • 9.2.3 Oncology
        • 9.2.4 and Others
      • 9.3. Market Analysis, Insights and Forecast - By End-user
        • 9.3.1 Hospitals & Clinics
        • 9.3.2 Diagnostic Centers
        • 9.3.3 and Others
      • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 9.4.1 China
        • 9.4.2 Japan
        • 9.4.3 India
        • 9.4.4 South Korea
        • 9.4.5 Taiwan
        • 9.4.6 Australia
        • 9.4.7 Rest of Asia-Pacific
  10. 10. MEA Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2018-2030
      • 10.1. Market Analysis, Insights and Forecast - By Type
        • 10.1.1. Diagnostic and Therapeutic
      • 10.2. Market Analysis, Insights and Forecast - By Application
        • 10.2.1 Neurology
        • 10.2.2 Cardiology
        • 10.2.3 Oncology
        • 10.2.4 and Others
      • 10.3. Market Analysis, Insights and Forecast - By End-user
        • 10.3.1 Hospitals & Clinics
        • 10.3.2 Diagnostic Centers
        • 10.3.3 and Others
      • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 10.4.1 Middle East
        • 10.4.2 Africa
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2023
      • 11.2. Company Profiles
        • 11.2.1 Lantheus Medical Imaging Inc. (U.S.)
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Cardinal Health (U.S.)
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Norgine B.V. (Netherlands)
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Nordion (Canada) Inc. (Canada)
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Bayer AG (Germany)
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Curium (France)
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Advanced Accelerator Applications (Novartis AG) (France)
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Bracco Diagnostic Inc. (U.S.)
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Jubilant Pharmova Limited (India)
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 GE Healthcare (General Electric Company) (U.S.)
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue Breakdown (USD billion, %) by Region 2023 & 2031
  2. Figure 2: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Breakdown (Units, %) by Region 2023 & 2031
  3. Figure 3: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  4. Figure 4: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  5. Figure 5: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  6. Figure 6: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  7. Figure 7: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F 2020 & 2031
  8. Figure 8: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F 2020 & 2031
  9. Figure 9: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by 68Ga 2020 & 2031
  10. Figure 10: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by 68Ga 2020 & 2031
  11. Figure 11: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by 68Cu 2020 & 2031
  12. Figure 12: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by 68Cu 2020 & 2031
  13. Figure 13: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by 11C 2020 & 2031
  14. Figure 14: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by 11C 2020 & 2031
  15. Figure 15: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Others] 2020 & 2031
  16. Figure 16: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Others] 2020 & 2031
  17. Figure 17: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by SPECT Radiopharmaceuticals [Technetium-99m 2020 & 2031
  18. Figure 18: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by SPECT Radiopharmaceuticals [Technetium-99m 2020 & 2031
  19. Figure 19: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Iodine-123 2020 & 2031
  20. Figure 20: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Iodine-123 2020 & 2031
  21. Figure 21: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Xenon-133 2020 & 2031
  22. Figure 22: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Xenon-133 2020 & 2031
  23. Figure 23: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Thallium-201 2020 & 2031
  24. Figure 24: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Thallium-201 2020 & 2031
  25. Figure 25: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Others]} 2020 & 2031
  26. Figure 26: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Others]} 2020 & 2031
  27. Figure 27: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Therapeutics {Ra-223 2020 & 2031
  28. Figure 28: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Therapeutics {Ra-223 2020 & 2031
  29. Figure 29: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Sm-153 2020 & 2031
  30. Figure 30: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Sm-153 2020 & 2031
  31. Figure 31: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Lu-177 2020 & 2031
  32. Figure 32: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Lu-177 2020 & 2031
  33. Figure 33: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by I-131 2020 & 2031
  34. Figure 34: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by I-131 2020 & 2031
  35. Figure 35: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Y-90 2020 & 2031
  36. Figure 36: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Y-90 2020 & 2031
  37. Figure 37: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Others} 2020 & 2031
  38. Figure 38: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Others} 2020 & 2031
  39. Figure 39: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  40. Figure 40: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  41. Figure 41: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  42. Figure 42: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  43. Figure 43: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Neurology 2020 & 2031
  44. Figure 44: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Neurology 2020 & 2031
  45. Figure 45: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Cardiology 2020 & 2031
  46. Figure 46: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Cardiology 2020 & 2031
  47. Figure 47: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Oncology 2020 & 2031
  48. Figure 48: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Oncology 2020 & 2031
  49. Figure 49: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Others 2020 & 2031
  50. Figure 50: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Others 2020 & 2031
  51. Figure 51: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End User 2023 & 2031
  52. Figure 52: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End User 2023 & 2031
  53. Figure 53: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End User 2023 & 2031
  54. Figure 54: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End User 2023 & 2031
  55. Figure 55: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Hospitals & Clinics 2020 & 2031
  56. Figure 56: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Hospitals & Clinics 2020 & 2031
  57. Figure 57: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Diagnostic Centers 2020 & 2031
  58. Figure 58: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Diagnostic Centers 2020 & 2031
  59. Figure 59: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (USD billion), by Others 2020 & 2031
  60. Figure 60: Global Nuclear Medicine/ Radiopharmaceuticals Market Forecast (Units), by Others 2020 & 2031
  61. Figure 61: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Region 2023 & 2031
  62. Figure 62: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Region 2023 & 2031
  63. Figure 63: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Region 2023 & 2031
  64. Figure 64: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Region 2023 & 2031
  65. Figure 65: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  66. Figure 66: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  67. Figure 67: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  68. Figure 68: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  69. Figure 69: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  70. Figure 70: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  71. Figure 71: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  72. Figure 72: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  73. Figure 73: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End-user 2023 & 2031
  74. Figure 74: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End-user 2023 & 2031
  75. Figure 75: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End-user 2023 & 2031
  76. Figure 76: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End-user 2023 & 2031
  77. Figure 77: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  78. Figure 78: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  79. Figure 79: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  80. Figure 80: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
  81. Figure 81: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  82. Figure 82: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  83. Figure 83: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  84. Figure 84: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  85. Figure 85: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  86. Figure 86: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  87. Figure 87: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  88. Figure 88: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  89. Figure 89: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End-user 2023 & 2031
  90. Figure 90: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End-user 2023 & 2031
  91. Figure 91: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End-user 2023 & 2031
  92. Figure 92: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End-user 2023 & 2031
  93. Figure 93: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  94. Figure 94: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  95. Figure 95: South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  96. Figure 96: South America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
  97. Figure 97: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  98. Figure 98: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  99. Figure 99: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  100. Figure 100: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  101. Figure 101: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  102. Figure 102: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  103. Figure 103: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  104. Figure 104: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  105. Figure 105: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End-user 2023 & 2031
  106. Figure 106: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End-user 2023 & 2031
  107. Figure 107: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End-user 2023 & 2031
  108. Figure 108: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End-user 2023 & 2031
  109. Figure 109: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  110. Figure 110: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  111. Figure 111: Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  112. Figure 112: Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
  113. Figure 113: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  114. Figure 114: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  115. Figure 115: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  116. Figure 116: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  117. Figure 117: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  118. Figure 118: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  119. Figure 119: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  120. Figure 120: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  121. Figure 121: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End-user 2023 & 2031
  122. Figure 122: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End-user 2023 & 2031
  123. Figure 123: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End-user 2023 & 2031
  124. Figure 124: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End-user 2023 & 2031
  125. Figure 125: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  126. Figure 126: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  127. Figure 127: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  128. Figure 128: Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
  129. Figure 129: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  130. Figure 130: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  131. Figure 131: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  132. Figure 132: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  133. Figure 133: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  134. Figure 134: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  135. Figure 135: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  136. Figure 136: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  137. Figure 137: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End-user 2023 & 2031
  138. Figure 138: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End-user 2023 & 2031
  139. Figure 139: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End-user 2023 & 2031
  140. Figure 140: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End-user 2023 & 2031
  141. Figure 141: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  142. Figure 142: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  143. Figure 143: MEA Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  144. Figure 144: MEA Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
  145. Figure 145: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Type 2023 & 2031
  146. Figure 146: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Type 2023 & 2031
  147. Figure 147: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Type 2023 & 2031
  148. Figure 148: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Type 2023 & 2031
  149. Figure 149: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Application 2023 & 2031
  150. Figure 150: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Application 2023 & 2031
  151. Figure 151: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Application 2023 & 2031
  152. Figure 152: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Application 2023 & 2031
  153. Figure 153: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by End User 2023 & 2031
  154. Figure 154: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by End User 2023 & 2031
  155. Figure 155: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by End User 2023 & 2031
  156. Figure 156: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by End User 2023 & 2031
  157. Figure 157: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion), by Country 2023 & 2031
  158. Figure 158: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units), by Country 2023 & 2031
  159. Figure 159: North America Nuclear Medicine/ Radiopharmaceuticals Market Revenue Share (%), by Country 2023 & 2031
  160. Figure 160: North America Nuclear Medicine/ Radiopharmaceuticals Market Volume Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  2. Table 2: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  3. Table 3: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  4. Table 4: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  5. Table 5: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  6. Table 6: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  7. Table 7: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Region 2018 & 2031
  8. Table 8: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Region 2018 & 2031
  9. Table 9: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  10. Table 10: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  11. Table 11: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  12. Table 12: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  13. Table 13: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End User 2018 & 2031
  14. Table 14: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End User 2018 & 2031
  15. Table 15: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Region 2018 & 2031
  16. Table 16: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Region 2018 & 2031
  17. Table 17: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  18. Table 18: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  19. Table 19: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  20. Table 20: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  21. Table 21: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  22. Table 22: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  23. Table 23: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  24. Table 24: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  25. Table 25: United States Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  26. Table 26: United States Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  27. Table 27: Canada Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  28. Table 28: Canada Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  29. Table 29: Mexico Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  30. Table 30: Mexico Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  31. Table 31: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  32. Table 32: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  33. Table 33: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  34. Table 34: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  35. Table 35: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  36. Table 36: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  37. Table 37: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  38. Table 38: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  39. Table 39: Brazil Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  40. Table 40: Brazil Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  41. Table 41: Argentina Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  42. Table 42: Argentina Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  43. Table 43: Rest of South America Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  44. Table 44: Rest of South America Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  45. Table 45: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  46. Table 46: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  47. Table 47: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  48. Table 48: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  49. Table 49: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  50. Table 50: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  51. Table 51: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  52. Table 52: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  53. Table 53: Germany Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  54. Table 54: Germany Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  55. Table 55: France Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  56. Table 56: France Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  57. Table 57: Italy Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  58. Table 58: Italy Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  59. Table 59: United Kingdom Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  60. Table 60: United Kingdom Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  61. Table 61: Netherlands Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  62. Table 62: Netherlands Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  63. Table 63: Rest of Europe Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  64. Table 64: Rest of Europe Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  65. Table 65: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  66. Table 66: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  67. Table 67: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  68. Table 68: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  69. Table 69: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  70. Table 70: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  71. Table 71: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  72. Table 72: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  73. Table 73: China Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  74. Table 74: China Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  75. Table 75: Japan Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  76. Table 76: Japan Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  77. Table 77: India Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  78. Table 78: India Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  79. Table 79: South Korea Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  80. Table 80: South Korea Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  81. Table 81: Taiwan Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  82. Table 82: Taiwan Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  83. Table 83: Australia Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  84. Table 84: Australia Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  85. Table 85: Rest of Asia-Pacific Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  86. Table 86: Rest of Asia-Pacific Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  87. Table 87: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  88. Table 88: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  89. Table 89: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  90. Table 90: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  91. Table 91: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End-user 2018 & 2031
  92. Table 92: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End-user 2018 & 2031
  93. Table 93: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  94. Table 94: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  95. Table 95: Middle East Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  96. Table 96: Middle East Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  97. Table 97: Africa Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  98. Table 98: Africa Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  99. Table 99: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Type 2018 & 2031
  100. Table 100: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Type 2018 & 2031
  101. Table 101: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Application 2018 & 2031
  102. Table 102: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Application 2018 & 2031
  103. Table 103: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by End User 2018 & 2031
  104. Table 104: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by End User 2018 & 2031
  105. Table 105: Global Nuclear Medicine/ Radiopharmaceuticals Market Revenue USD billion Forecast, by Country 2018 & 2031
  106. Table 106: Global Nuclear Medicine/ Radiopharmaceuticals Market Volume Units Forecast, by Country 2018 & 2031
  107. Table 107: U.S. Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  108. Table 108: U.S. Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
  109. Table 109: Canada Nuclear Medicine/ Radiopharmaceuticals Market Revenue (USD billion) Forecast, by Application 2018 & 2031
  110. Table 110: Canada Nuclear Medicine/ Radiopharmaceuticals Market Volume (Units) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 19.5% from 2018-2032
Segmentation
    • By Type
      • Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F
      • 68Ga
      • 68Cu
      • 11C
      • Others]
      • SPECT Radiopharmaceuticals [Technetium-99m
      • Iodine-123
      • Xenon-133
      • Thallium-201
      • Others]}
      • Therapeutics {Ra-223
      • Sm-153
      • Lu-177
      • I-131
      • Y-90
      • Others}
    • By Application
      • Neurology
      • Cardiology
      • Oncology
      • Others
    • By End User
      • Hospitals & Clinics
      • Diagnostic Centers
      • Others
  • By Geography
    • North America
      • U.S.
      • Canada

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...